Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Long-Term Care Deals Hold Steady in Q2:17
Merger and acquisition activity stayed virtually even in the second quarter, down 1% from the previous quarter, to 75 transactions. The quarter’s deal volume makes up 24% of the 315 deals announced within the past 12 months. Q2:17’s deal volume is 17% lower than the same period a year earlier. Source: HealthCareMandA.com, July 2017 Based on revealed prices, approximately $9.7 billion was committed to finance second quarter deals, an increase of 574% compared with the previous quarter and 299% higher than the same period in 2016. The second quarter accounted for 47% of the $20.6 billion spent in the last 12 months. Forty-four of the 75 deals disclosed prices, and two were more than $1... Read More »
WebMD Goes Private in $3.6 Billion Deal
A portfolio company of KKR (NYSE: KKR) just announced the 99th eHealth deal of 2017, and the second largest eHealth deal in our M&A database dating back to 1993. On July 24, 2017, KKR portfolio company Internet Brands, an online media and software services organization, announced the acquisition of WebMD Health Corp. (NASDAQ: WBMD). The company provides health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms and health-focused publications. The deal comes five months after New York-based WebMD said it would explore strategic options following a slowdown in... Read More »
Home Health and Hospice Sector Hit by Headwinds
The Home Health & Hospice sector has experienced a few headwinds in 2017. Besides the ongoing labor shortage, reimbursement levels would be severely impacted by the passage of the Senate Republicans’ Better Care Reconciliation Act, which curtails federal spending on Medicaid beginning in 2020. Little surprise, then, that deal volume faded in the second quarter, to nine transactions. Deal volume in Q2:17 fell to 10 transactions, which represent 18% of the 55 deals announced in the past 12 months. Compared with the same period a year earlier, deal volume was down 31%. Source: HealthCareMandA.com, July 2017 None of the deals announced disclosed financial terms. Dollars Spent on Home... Read More »Health Care M&A Weekly Deals, The Week Ending July 21, 2017
Health Care M&A Weekly Deals, The Week Ending July 21,... Read More »Behavioral Health Deals Tumble in Q2:17
Deal activity in the Behavioral Health Care sector plummeted in Q2:17, down 50% compared with the previous quarter, and down 53% compared with the same quarter a year earlier. The quarter’s total of eight deals represents 21% of the 39 transactions announced in the past 12 months. In fact, those two quarters—Q1:17 and Q2:16—had the highest number of deals in the preceding 12 months, so the news is not quite as dire as it appears. The second quarter’s deal volume is equal to that of Q4:16 and Q3:16. The passage of the 21st Century Cures Act in December 2016 brought additional focus and spending on substance abuse programs, particularly for opioid addiction, and mental health issues.... Read More »
Alere Spins Off Assets to Aid Abbott Merger
Since February 2016, we’ve followed the testy merger between Abbott (NYSE: ABT) and Alere’s (NYSE: ALR) agreement to merge, followed by the respective lawsuits, and then the price renegotiation. Half way through 2017, the $5.3 billion deal is getting closer to completion, as Alere spins off some assets to comply with antitrust regulations. The first to go is Alere’s Triage® MeterPro cardiovascular (CV) and toxicology assets (“Triage business”), together with the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”). The buyer is Quidel Corporation (NASDAQ: QDEL), which will acquire the Triage business, including real estate for the San... Read More »Sanofi Rationalizes Its Vaccine Portfolio
Early in July, Sanofi (NYSE: SNY) announced an acquisition and a divestment, both affecting its vaccine business. In a recent annual filing, Sanofi labelled its vaccine unit as an area of priority to sustain its leadership role. To that end, the company has expanded its influenza vaccine portfolio and shed its small pox vaccine business, including its related contract with the Center for Disease Control (CDC). In 2016, Sanofi generated $5.04 billion in net sales from its vaccine products. Its influenza vaccine unit was the second largest contributor to this total, accounting for $1.7 billion in net sales that year, a record year for Sanofi’s influenza campaign. Sanofi Pasteur, the... Read More »Long-Term Care Deal Value Surges in Q2:17
The dollar volume of publicly announced seniors housing and care acquisitions in the second quarter of 2017 surged to $9.7 billion, a nearly 600% increase over the first quarter’s volume of $1.4 billion. The number of announced transactions in the second quarter (75) was basically even with the first quarter (76), according to new acquisition data from HealthCareMandA.com. The dollar volume is the highest since the second quarter of 2014. Driving the dollar volume were two billion-dollar acquisitions, including the acquisition of Care Capital Properties by Sabra Health Care REIT in a transaction valued close to $4.0 billion, as well as the acquisition of Hawthorn Retirement Group by... Read More »Managed Care Deals Dry Up
Now that the mega-mergers of 2015 have been squashed, deal activity in the Managed Care sector could use a shot in the arm. Through mid-July 2017, only 10 deals have been announced in this sector, on par with 2016’s total of 20 deals. At this rate, it’s unlikely that the sector will reach its 2015 peak of 43 deals. Although 2015 was not a record year, it was the second highest of the century, behind 2000’s total of 47 deals. The Big Four health insurers have ceded the playing field to the smaller players, and financial buyers are stepping in. In 2015, managed care companies accounted for 72% of the 43 deals announced that year and financial buyers only accounted for 5%. Molina... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
